72 related articles for article (PubMed ID: 1793071)
1. Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation.
Saeed SA; Mahmood F; Naqvi A; Jafary MH
Agents Actions Suppl; 1991; 34():351-7. PubMed ID: 1793071
[No Abstract] [Full Text] [Related]
2. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
Wang XD; Bian RL
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
[TBL] [Abstract][Full Text] [Related]
3. Effect of ketotifen and disodium cromoglycate on human platelet aggregation.
García Mesa M; Arruzazabala Valmaña ML
Allergol Immunopathol (Madr); 1989; 17(1):33-4. PubMed ID: 2502003
[TBL] [Abstract][Full Text] [Related]
4. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
Adamus WS; Heuer H; Meade CJ
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
Church MK
Br J Dermatol; 2010 Dec; 163(6):1330-2. PubMed ID: 20819087
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
7. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
9. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
Kosugi T; Nakamura M; Saitoh S; Kinjoh K
Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
11. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
12. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of TBN on platelet aggregation in rabbit].
Xu CL; Shan LC; Sun YW; Wang YQ
Zhong Yao Cai; 2010 Sep; 33(9):1450-3. PubMed ID: 21243778
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
[TBL] [Abstract][Full Text] [Related]
16. Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis.
Morley J; Page CP; Mazzoni L; Sanjar S
Ann Allergy; 1986 Apr; 56(4):335-40. PubMed ID: 3083731
[No Abstract] [Full Text] [Related]
17. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
18. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA
Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131
[No Abstract] [Full Text] [Related]
19. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
